Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Micah Griffin

Physician Assistant Branson, MO Physician Assistant

NPI 1700427358 CMS profile 10474977

110 Business Park Dr Ste C, Branson, MO 65615

Open in the dashboard

General payments

$6,028

294 records reported · program years 2021–2025

Research payments

$2,235

Paid to them · 3 records reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Micah Griffin of Branson, MO is reported in the CMS Open Payments database as having received $6,028 across 294 general payments and $2,235 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $353 14
2024 General $80 3
2024 Research $2,235 3
2023 General $1,216 53
2022 General $2,985 140
2021 General $1,394 84

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Micah Griffin
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Micah Griffin were reported at $353. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Micah Griffin Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $1,394 $132 $37–$438 $132
2022 $2,985 $155 $48–$522 $149
2023 $1,216 $167 $52–$557 $160
2024 $80 $178 $55–$600 $164
2025 $353 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. AbbVie, Inc. $1,099 64 payments
  2. Amgen Inc. $862 39 payments
  3. Janssen Biotech, Inc. $780 35 payments
  4. Lilly USA, LLC $554 29 payments
  5. AstraZeneca Pharmaceuticals LP $397 9 payments
  6. Mallinckrodt Hospital Products Inc. $352 8 payments
  7. Novartis Pharmaceuticals Corporation $281 16 payments
  8. UCB, Inc. $256 13 payments
  9. Biohaven Pharmaceutical Holding Company Ltd. $212 19 payments
  10. Lundbeck LLC $155 11 payments
  11. Other $1,080 51 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $5,665 290 payments
  2. Education $363 4 payments
Products named General payments · program years 2021–2025
  1. TREMFYA $715 24 payments
  2. RINVOQ $546 25 payments
  3. SIMPONI ARIA $415 27 payments
  4. Otezla $379 17 payments
  5. Enbrel $370 23 payments
  6. QULIPTA $358 25 payments
  7. ACTHAR $352 8 payments
  8. SAPHNELO $345 6 payments
  9. STELARA $283 14 payments
  10. TALTZ $279 22 payments
  11. Other $3,811 204 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2021–2025
  1. Lexicon Pharmaceuticals, Inc. $2,235 3 payments

Records

297 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Missouri

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record